International Journal of Pharmaceutical Sciences and Clinical Research (IJPSCR) - Publication Ethics

ijpscr is committed to the highest standards of publication ethics in pharmaceutical research, following comprehensive guidelines from leading international organizations. The Committee on Publication Ethics (COPE) provides best practices for publication ethics and handling of misconduct, ensuring the journal maintains ethical integrity in all editorial processes. The International Committee of Medical Journal Editors (ICMJE) establishes standards for authorship, peer review, and scientific conduct that the journal follows to maintain academic quality. The World Association of Medical Editors (WAME) provides guidance on editorial independence, peer review, and publication ethics that shape the journal's ethical framework. The Council of Science Editors (CSE) guidelines ensure high standards in scientific communication and editorial practices. The Open Access Scholarly Publishers Association (OASPA) provides standards for open access publishing that the journal follows to ensure ethical and transparent dissemination of research.**

ijpscr is committed to maintaining the highest standards of research integrity through comprehensive ethical principles that guide all aspects of research and publication. Honesty is fundamental, requiring honest reporting of research, procedures, data, and outcomes to ensure the credibility and reliability of published work. Transparency is emphasized through transparent reporting of methods, data, and results, allowing readers to evaluate research findings and reproduce studies when necessary. Accountability is enforced through accountability for research conduct and reporting, ensuring that researchers take responsibility for their work and its implications. Professionalism is maintained through professional conduct in all aspects of research, from initial design through publication and dissemination. Respect is demonstrated through respect for research participants, colleagues, and the research community, fostering an environment of collaboration and mutual support in advancing pharmaceutical knowledge.

ijpscr maintains rigorous publication ethics to ensure the quality and integrity of all published content. Originality is strictly enforced, requiring that all submissions must be original and unpublished work that has not been previously disseminated in other venues. Authorship standards ensure proper authorship attribution and contribution, with all named authors having made substantial intellectual contributions to the research. Plagiarism is strictly prohibited through a comprehensive plagiarism policy with a less than 12% similarity threshold to maintain academic integrity and originality. Data Integrity requirements mandate accurate and transparent data reporting, ensuring that research findings are honestly presented and reproducible. Conflict of Interest policies require full disclosure of potential conflicts that could influence research outcomes or interpretations.

Authors must ensure comprehensive adherence to research conduct standards that maintain the integrity and quality of pharmaceutical research. Our scope encompasses ensuring original work, data accuracy, methodological rigor, proper attribution, and regulatory compliance. Authors must also adhere to specific ethical standards that address the unique challenges of conducting pharmaceutical research in organizational and commercial contexts, including data privacy, confidentiality, informed consent, ethical approval, and professional standards. Furthermore, authors must meet all of the following criteria to ensure appropriate and ethical authorship attribution, including substantial contribution, drafting, final approval, accountability, and pharmaceutical responsibility. Authors must not engage in any prohibited practices that compromise research integrity or ethical standards, including plagiarism, data fabrication, data falsification, duplicate publication, citation manipulation, salami publishing, and gift authorship.

Reviewers must adhere to strict ethical standards to ensure the integrity and quality of the peer review process. Confidentiality is essential, requiring reviewers to maintain manuscript confidentiality and respect intellectual property throughout the review process and beyond. Objectivity is fundamental, requiring reviewers to provide unbiased, constructive, and professional feedback that helps authors improve their work regardless of personal opinions or preferences. Expertise must be demonstrated by only reviewing manuscripts within their area of expertise, ensuring that evaluations are informed and knowledgeable. Timeliness is important, requiring reviewers to complete reviews within the specified timeframe of 21 days to maintain efficient processing of manuscripts. Conflict Declaration is mandatory, requiring reviewers to decline review assignments if conflicts of interest exist that could compromise their objectivity or create perceptions of bias.

Reviewers should maintain high standards of professional conduct that contribute to a positive and productive review process. Respect is demonstrated by treating authors with professional courtesy and respect, recognizing the effort and investment that authors have made in their research. Constructive Feedback should be provided through specific, actionable, and constructive recommendations that help authors strengthen their manuscripts and improve the quality of their research. Pharmaceutical Sensitivity must be handled appropriately, ensuring that pharmaceutical-sensitive data and information are treated with appropriate care and discretion. Methodological Rigor should be evaluated rigorously, assessing the soundness and appropriateness of research methods and analytical approaches. Practical Relevance should be assessed to determine the practical pharmaceutical relevance and implications of research findings, ensuring that published work has value for pharmaceutical practice and decision-making.

Reviewers should have comprehensive qualifications that ensure high-quality peer review evaluations. An Academic Background with an advanced degree in pharmaceutical, clinical research, analytics, or related field provides the theoretical foundation necessary for evaluating research quality and contribution. Research Experience with a minimum of 5 years research experience in relevant area ensures familiarity with research methodologies, current literature, and emerging trends in the field. A Publication Record with an established publication record in peer-reviewed journals demonstrates the reviewer's ability to produce high-quality research and understand publication standards. Ethical Training with understanding of research ethics and publication standards ensures that reviewers can evaluate manuscripts according to ethical guidelines and professional standards. Industry Experience with relevant industry experience is preferred to provide practical perspectives on pharmaceutical research applications and implications.

Editors must uphold the highest ethical standards in all editorial decisions and processes. Fair Evaluation requires making decisions based on merit, quality, and relevance without influence from personal relationships, institutional affiliations, or commercial interests. Transparency must be maintained through clear and transparent editorial policies and processes that are communicated to all stakeholders. Confidentiality must be protected for author, reviewer, and editorial staff confidentiality throughout the publication process. Quality Standards must be maintained through high publication standards and quality that ensure the journal publishes only the best research. Accountability must be accepted for editorial decisions and processes, with editors taking responsibility for the quality and integrity of published content.

Editors must ensure that published research maintains high standards of pharmaceutical research integrity. Pharmaceutical Relevance should be emphasized through practical pharmaceutical applications and implications that make research valuable to practitioners and decision-makers. Methodological Soundness must be ensured through sound pharmaceutical research methodology that employs appropriate designs, data collection methods, and analytical techniques. Data Quality must be maintained through high-quality pharmaceutical data and analysis that support research findings and conclusions. Practical Value should be demonstrated through value for pharmaceutical decision-making and practice, ensuring that research contributes to improved pharmaceutical performance and outcomes. Ethical Compliance requires strict adherence to ethical standards in all aspects of research and publication.

Editors must effectively manage conflicts of interest to maintain editorial integrity and fairness. Disclosure is required for all potential conflicts of interest that could influence editorial decisions or create perceptions of bias. Recusal is necessary when editors must recuse from decisions involving conflicts to ensure objective evaluation and decision-making. Transparency must be maintained through transparent editorial processes that are open to scrutiny and accountability. Fairness must be ensured through equal treatment of all submissions regardless of author characteristics, institutional affiliations, or research topics. An Appeals Process should be provided through fair and transparent appeal mechanisms that allow authors to challenge editorial decisions they believe are unfair or incorrect.

Pharmaceutical Regulations:

ijpscr maintains comprehensive compliance with pharmaceutical regulations to ensure ethical and legal research practices. GDPR Compliance ensures adherence to the General Data Protection Regulation, protecting personal data and privacy rights of research participants and stakeholders. Data Protection involves compliance with data protection laws that govern the collection, storage, and processing of personal and pharmaceutical information. Pharmaceutical Ethics compliance ensures adherence to pharmaceutical ethics standards that guide professional conduct and research integrity in commercial contexts. Industry Standards compliance involves following industry-specific standards that regulate pharmaceutical practices and research in various sectors. International Standards compliance ensures adherence to international pharmaceutical standards that facilitate global research collaboration and knowledge exchange.

Pharmaceutical Standards:

The journal maintains strict adherence to pharmaceutical standards that ensure quality and professionalism in published research. SEC Standards compliance involves following Securities and Exchange Commission standards that govern financial reporting and pharmaceutical disclosures. GAAP Compliance ensures adherence to Generally Accepted Accounting Principles that standardize financial reporting and pharmaceutical analysis. ISO Standards compliance involves following International Organization for Standardization guidelines that ensure quality and consistency in pharmaceutical processes and research. Professional Standards compliance requires adherence to professional association standards that guide ethical conduct and research practices in pharmaceutical disciplines. Corporate Governance compliance ensures adherence to corporate governance standards that promote transparency, accountability, and ethical leadership in pharmaceutical organizations.

Pharmaceutical Ethics:

ijpscr follows comprehensive pharmaceutical ethics standards that guide research conduct and publication practices. Harvard Pharmaceutical School research standards provide guidance on rigorous pharmaceutical research methodology and ethical conduct in academic and pharmaceutical contexts. AACSB compliance involves following Association to Advance Collegiate Schools of Pharmaceutical standards that ensure quality in pharmaceutical education and research. EFMD standards compliance involves adhering to European Foundation for Clinical Research Development guidelines that promote excellence in pharmaceutical education and research. Pharmaceutical Roundtable principles compliance ensures adherence to pharmaceutical principles that promote ethical corporate behavior and social responsibility. UN Principles compliance involves following UN Global Compact principles that promote sustainable and ethical pharmaceutical practices worldwide.

Pharmaceutical Research Misconduct:

Pharmaceutical Research Misconduct encompasses serious violations of research integrity that undermine the credibility and reliability of pharmaceutical research. Fabrication involves creating false or misleading pharmaceutical data that misrepresent reality or support invalid conclusions. Falsification includes manipulating pharmaceutical data, methods, or results to achieve desired outcomes or hide inconvenient findings. Plagiarism involves using others' work without proper attribution, including text, ideas, data, or methodologies without appropriate citation. Duplicate Publication includes publishing the same work in multiple journals without appropriate cross-referencing or justification, artificially inflating publication metrics. Authorship Misconduct involves gift authorship, ghost authorship, or undeserved authorship where individuals are included as authors without making substantial contributions. Data Misconduct includes misrepresentation of data sources or analysis, including selective reporting or inappropriate data manipulation. Ethical Violations involve serious breaches of research ethics that compromise the integrity of research or harm participants and stakeholders.

The investigation process for alleged misconduct follows a structured approach to ensure fairness and thoroughness. Initial Assessment involves preliminary evaluation of allegations and evidence to determine whether formal investigation is warranted. Evidence Gathering includes collection of relevant documentation and evidence from all parties involved, including manuscripts, data, correspondence, and other supporting materials. Expert Review involves assessment by pharmaceutical research ethics experts who can evaluate the allegations and evidence with appropriate expertise and objectivity. Author Response provides opportunity for author to respond to allegations and present their perspective on the alleged misconduct. Final Decision involves determination by editorial board based on evidence, following established procedures and ensuring due process for all parties involved.

Sanctions and Corrections are applied proportionally based on the severity and nature of the misconduct. Retraction involves removal of published articles with proven misconduct to maintain the integrity of the scholarly record. Expression of Concern includes notice about potential issues with published work when conclusive evidence is not available but concerns exist. Correction involves publication of errata or corrigenda for identified errors that do not constitute misconduct but affect the accuracy of published work. Author Ban includes temporary or permanent publication ban for serious misconduct to protect the journal and research community from repeat violations. Institution Notification involves notification to author's institution for serious violations that may require institutional investigation or action.

Pharmaceutical Ethics Review:

ijpscr implements comprehensive pharmaceutical ethics review processes to ensure the integrity and quality of published research. Plagiarism Detection utilizes automated plagiarism checking with a less than 12% threshold to identify potential plagiarism and maintain academic integrity. Data Verification involves validation of pharmaceutical data and analysis to ensure accuracy, reliability, and appropriate interpretation of research findings. Methodology Review includes assessment of research methodology and design to ensure that research approaches are sound, appropriate, and systematically applied. Author Verification includes confirmation of author contributions and qualifications to ensure proper attribution and expertise alignment with research content. Conflict Screening involves systematic conflict of interest screening to identify and manage potential conflicts that could compromise research integrity or editorial decisions.

Pharmaceutical Quality Assurance:

The journal maintains rigorous pharmaceutical quality assurance standards to ensure the relevance and impact of published research. Practical Relevance involves assessment of practical pharmaceutical relevance to ensure that research addresses real-world pharmaceutical challenges and offers actionable insights for practitioners. Methodological Rigor includes evaluation of research methodology rigor to ensure that research designs and analytical approaches are sound and appropriate for addressing research questions. Data Quality involves assessment of data quality and analysis to ensure that research findings are based on reliable, valid, and appropriately analyzed data. Industry Standards compliance involves adherence to industry standards and practices to ensure that research is relevant and applicable to current pharmaceutical environments and challenges. Professional Standards adherence requires compliance with professional pharmaceutical standards that guide ethical conduct and research practices in pharmaceutical disciplines.

Authors must ensure comprehensive data clinical research practices that protect data integrity and participant rights. Data Accuracy requires accurate and reliable data collection and reporting to ensure that research findings are based on valid and trustworthy information. Data Privacy involves protection of sensitive pharmaceutical and personal data collected during research, complying with relevant privacy regulations and ethical guidelines. Data Security includes secure storage and transmission of data to prevent unauthorized access, loss, or compromise of research information. Data Sharing involves appropriate data sharing where possible and ethical, balancing transparency with privacy and confidentiality concerns. Data Documentation requires clear documentation of data sources and methods to ensure reproducibility and transparency of research processes.

Authors must maintain strict confidentiality standards to protect sensitive information and research participants. Pharmaceutical Confidentiality involves protection of confidential pharmaceutical information that could harm organizations or individuals if disclosed. Participant Privacy includes protection of research participant privacy through anonymization, secure storage, and limited access to personal information. Institutional Confidentiality involves protection of institutional data that could compromise organizational interests or relationships. Commercial Confidentiality includes protection of commercial information that could affect competitive advantage or pharmaceutical operations. Legal Confidentiality requires compliance with legal confidentiality requirements that govern research data and participant information.

Authors should provide comprehensive transparency in research reporting to enable evaluation and reproduction of findings. Methodology Details includes detailed description of research methodology to allow readers to understand and evaluate research approaches and techniques. Data Sources involves clear identification of data sources to enable verification of data quality and appropriateness for research purposes. Analysis Methods includes description of data analysis methods to ensure transparency in how data were processed and interpreted. Limitations requires acknowledgment of research limitations to provide honest assessment of study constraints and boundaries. Funding Sources involves disclosure of funding sources and conflicts to ensure transparency about potential influences on research.

ijpscr promotes comprehensive accessibility to maximize the impact and reach of published research. Open Access ensures open access to published research, making findings available to global audiences without barriers to access. Data Sharing promotes data sharing where ethically and legally appropriate to enable verification, extension, and application of research findings. Methodological Transparency involves transparent reporting of methods to enable evaluation and reproduction of research by other scholars. Reproducibility supports research reproducibility and verification through detailed reporting and availability of research materials and data. Global Access ensures global access to research findings through digital platforms and distribution channels that reach diverse international audiences.

The ijpscr Ethics Office provides comprehensive support and oversight for ethical research and publication practices. Email communication is available at editor.ijpscr@gtspress.org for inquiries about ethical guidelines, reporting concerns, or seeking guidance on research ethics matters. Phone support is provided at +91 97885 35227 for urgent ethical matters or direct communication with ethics office staff. The physical office is located at GTS Press Ethics Office, Coimbatore, India, serving as the central hub for ethical oversight and compliance activities. The ethics website at https://gtspress.org/ijpscr/ethics provides access to detailed ethics guidelines, resources, and reporting mechanisms for authors, reviewers, and editorial staff.

ijpscr maintains comprehensive mechanisms for reporting research and publication misconduct. Anonymous Reporting includes a confidential reporting system available for individuals who wish to report concerns without revealing their identity, protecting whistleblowers from potential retaliation. Formal Complaints require written complaints with evidence required to enable thorough investigation and fair assessment of alleged misconduct. Investigation Timeline ensures 30-60 days for resolution, providing timely response while allowing thorough investigation of allegations. An Appeals Process offers a 21-day appeal window for decisions, allowing parties to appeal outcomes they believe are unfair or incorrect. Protection includes protection for whistleblowers and reporters to prevent retaliation and encourage reporting of ethical concerns.

The journal provides extensive ethics support services to promote ethical research and publication practices. Ethics Consultation offers ethics consultation for authors and reviewers who need guidance on ethical issues or concerns during research and publication processes. Training includes ethics training for editorial board and reviewers to ensure understanding of ethical standards and best practices. Guidelines provide detailed ethics guidelines and resources that offer comprehensive guidance on ethical research conduct and publication practices. Compliance involves compliance monitoring and support to ensure adherence to ethical standards across all aspects of journal operations. Best Practices promotes best practices in research ethics through education, resources, and examples of ethical conduct in pharmaceutical research.